Welcome to our dedicated page for Psychemedics news (Ticker: PMD), a resource for investors and traders seeking the latest updates and insights on Psychemedics stock.
Psychemedics Corp (PMD) delivers cutting-edge hair analysis solutions for substance abuse detection, serving corporations and government agencies worldwide. This news hub provides investors and professionals with essential updates on the company's operational milestones and industry leadership.
Access consolidated reports on quarterly earnings, scientific advancements, and regulatory developments shaping the drug testing sector. Our repository includes press releases about new service launches like ketamine detection, strategic partnerships, and innovations such as Quartile Reporting technology.
This resource enables stakeholders to monitor PMD's patented testing methodologies and compliance solutions. Bookmark this page for streamlined access to verified updates about workplace safety initiatives and forensic science breakthroughs that define the company's market position.